M&T Bank’s Moderna MRNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-5
Closed -$11K 1612
2021
Q4
$11K Hold
5
﹤0.01% 1558
2021
Q3
$62K Hold
5
﹤0.01% 1501
2021
Q2
$10K Buy
+5
New +$894 ﹤0.01% 1564
2021
Q1
Sell
-5
Closed -$1K 1657
2020
Q4
$1K Buy
+5
New +$506 ﹤0.01% 1691

Other funds holding MRNA

M&T Bank's MRNA Position: Q2 2026 in Review

M&T Bank increased its Moderna (MRNA) stake by 25% in Q2 2026, buying an estimated $386K and bringing the position to 36,733 shares worth $2.57M. The position accounts for 0.01% of the portfolio, ranked #571.

M&T Bank first reported a position in MRNA in Q1 2020 and has held it in 26 quarters since. The position peaked at $5.69M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • M&T Bank held 36,733 shares of Moderna worth $2.57M as of Q2 2026.
  • M&T Bank bought 7,454 Moderna shares in Q2 2026, an estimated $386K.
  • Moderna made up 0.01% of M&T Bank's portfolio in Q2 2026, its #571 holding.
  • M&T Bank first reported a position in Moderna in Q1 2020 and has held it in 26 quarters since.
  • M&T Bank's Moderna position peaked at $5.69M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on M&T Bank's 13F filing for Q2 2026, filed 4 Aug 2026.